An educational tool to assist in the management of hepatic metastases in patients with colorectal cancer

Welcome Methods Authorship Strengths/Weaknesses
Using MetResect Principles Anatomy Tutorial
Selection Options By Category By Faculty By Case Matching
Overview of Resources References by Author References by Topic Expert Comments by Topic
North American Asian European World Wide

Clinical Trials in North America

US Studies

NSABP C-11: A Phase III Study Evaluating the Role of Perioperative Chemotherapy in Patients With Potentially Resectable Hepatic Colorectal Metastases (NCT01189227)

International, Phase II Study of CyberKnife® for Hepatic Metastases From Colorectal Cancer (NCT01318447)

A Phase I/II Trial of Radioimmunotherapy (Y-90 cT84.66), Gemcitabine and Hepatic Arterial Infusion of Fudr for Metastatic Colorectal Carcinoma to the Liver (NCT00645710)

A Phase II Trial of Radioimmunotherapy (Y-90 M5A) Following Hepatic Resection and FOLFOX Chemotherapy for Metastatic Colorectal Carcinoma to the Liver (NCT01320683)

Phase II study of Neoadjuvant XELOX/AVASTIN Therapy for Nonresectable Colorectal Liver Metastases With Secondary Hepatic Resection/Radiofrequency (NCT00408772)

Phase II Study of Drug-eluting Irinotecan Beads (DEBIRI) in Refractory Metastatic Colorectal Cancer With Liver-only or Liver-predominant Disease (NCT01285102)

Safety Profile Assessment of TheraSphere® Yttrium-90 Glass Microspheres Used for Treatment of Metastatic Liver Disease From Primary Colorectal, Neuroendocrine, Cholangiocarcinoma, Melanoma, and Breast Cancers Refractory to Chemotherapy: A Phase II Pilot Study (NCT01290536)

Canadian Study

A Phase II Study of Fractionated Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors (NCT00691691)


Copyright © 2008-2009 Research To Practice. All Rights Reserved.

Contact/Evaluate MetResect